Answers are grounded in this paper and cite their sources.
The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus (2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks.Among several epidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is an important measure to track record the overall proportion/ratio of the cumulative number of infected patients with the known outcome (confirmed, recovered, or deceased).Considering the ongoing fatality rate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viral vaccine development are discussed herein.The prompt identification of high-risk entities to confront the uncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement to tackle the current COVID-19 severity.Moreover, the protein visualization available at the viral surface/ body can give further insight into the appropriate vaccine development.
No takes yet. Share an insight, caveat, or question.
Bilal et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: